A responsible summary is that epithalon has shown biologically interesting cellular-aging signaling, that one core mechanism has begun to be independently replicated, and that whether and how this matters clinically in humans remains an open question
Limitations of Current Research Many studies are preclinical Human mechanistic trials remain limited Microbiome responses vary individually Diet, sleep, stress, and medications influence outcomes GLP-1 regulation is multi-factorial The microbiome is one variable within a complex endocrine network
Month 1-2: Establish your baseline on Semaglutide or Tirzepatide
The utility for each health state in this study was as recommended in a review of utility values for type 2 diabetes and its complications [22]
The thoughts come less often, and when they do, they carry less urgency
Avoid caffeine, alcohol, spicy foods, and dairy, as these can exacerbate symptoms